Skip to main content
. Author manuscript; available in PMC: 2019 Jun 14.
Published in final edited form as: J Med Chem. 2018 May 16;61(11):4860–4882. doi: 10.1021/acs.jmedchem.8b00168

Scheme 1:

Scheme 1:

a) SOCl2, CH3OH, rt, 15 h, 98%; b) PTSA, NaNO2 then NaN3, H2O, CH3CN, rt, 15 h, 63%; c) 4-ethynyltrifluorotoluene, sodium ascorbate, CuSO4, THF, H2O, rt, 1 h, 84%; d) LiOH, MeOH, 60 °C, 2 h, 76%; e) B2pin2, KOAc, PdCl2(dppf), dioxane, 70 °C, 15 h, 87%; f) i) 10% NaOH, H2O2, THF, 0 °C, 0.5 h; ii) KOH, MeOH, water, 50 °C, 5 h, 86%.